Abstract
The diagnosis of myocardial vitality is used for patients with advanced coronary heart disease and heart failure in order to identify candidates for revascularising procedures. The basic principle is the differentiation between ischemically compromised but still viable myocardium (hibernating myocardium) and non-viable scar tissue. Nuclear cardiac procedures, especially positron emission tomography (PET), play a primary role in establishing this diagnosis. PET is still seen as the gold standard. Magnetic resonance imaging is a more recent and increasingly popular procedure due to its estimation of viability through excellent spatial clarity. In this review, the basic principles and data base for both procedures are discussed for this specific indication.
| Translated title of the contribution | Myocardial viability assessment. The roll of nuclear medicine and magnetic resonance imaging |
|---|---|
| Original language | German |
| Pages (from-to) | 45-54 |
| Number of pages | 10 |
| Journal | Clinical Research in Cardiology Supplements |
| Volume | 2 |
| Issue number | 1 |
| DOIs | |
| State | Published - Dec 1 2007 |
Keywords
- Heart failure
- MRI
- Myocardiac viability
- Nuclear cardiology
- PET
ASJC Scopus subject areas
- Structural Biology
- Molecular Biology
- Radiology Nuclear Medicine and imaging